Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › BLUEJET

BLUEJET

Blue Jet Healthcare Limited
Micro-capPharma ↗

What the six lenses say about BLUEJET — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹569.0
2026-09-08
VWAP · 1Y anchor
₹523
+8.8% from VWAP
P/E · TTM
—
no TTM EPS
52-week range
58%
position low→high
RSI(14)
41
momentum

Own sector index

Pharma ↗
Overweight

1M

+0.4%

3M

+10.5%

1Y

+22.0%

Breadth >EMA21

56%

How BLUEJET’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
8.5
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Micro-cap cohortDRaw
TechnicalD890›

The actual numbers

Price vs VWAP (1y)+8.8%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+5.6%
Price vs 50-EMA-0.3%
RSI(14)41
RS vs Nifty 500 · 3M+21.8%
RS vs sector · 3M+15.7%
52-week range58%
Volume vs 30d avg0.57×
Volume vs 60d avg0.60×
ATR(14) · volatility18.7
Bollinger width · vol contraction0.062
FundamentalD1083›

The actual numbers

Return on equity (ROE)52.1%
Return on capital (ROCE)57.3%
Operating margin35.8%
Net margin26.9%
Debt / equity0.00×

Full 8-quarter history in the financials table below.

ValuationD422›

The actual numbers

52-week range58%
CatalystD330›

The actual numbers

Earnings & momentum25
Capital actions18
Governance74

Every filing in the corporate-announcements panel below.

FlowD960›

The actual numbers

Promoter holding79.8%
Delivery · 30d avg49.7%
Up/down-day asymmetry-1.5pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D8 + D9 ) ÷ 2 = 8.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
87
Conviction score 87/100 · avg-decile strength 8.5/10
Conviction score87/100›
TechnicalD8›
FundamentalD10›
ValuationD4›
CatalystD3›
FlowD9›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.4pp
-0.4pp
+0.3pp
+23.4pp
+50.4pp
-17.5pp
Nifty 500
Broad-market baseline
+0.3pp
-0.4pp
-0.8pp
+21.8pp
+44.7pp
-22.7pp
Sector
Own-sector index
—
—
-3.6pp
+15.7pp
+31.6pp
-43.5pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

BLUEJET daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
569.05-0.75

Relative strength

RS vs baseline · rebased to 100

BLUEJET ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
110.47+0.32

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

No quarterly financials available.

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 18 Aug '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 7 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 3 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 3 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 28 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 27 Jul '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 Jul '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 9 Jul '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 9 Jul '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 6 Jul '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 6 Jul '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 15 Jun '26
    LOWgovernance
    Spurt in Volume
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds BLUEJET

Mutual funds holding BLUEJET (7)

FundWeightAUM ₹crGrade
ICICI Pru Pharma Healthcare Diag Gr2.39%6,803
UTI Small Cap Reg Gr0.90%5,263
UTI Healthcare Reg Gr1.13%1,371
Groww Multicap Reg Gr2.74%924
ITI Large & Mid Cap Reg Gr0.96%740
Groww Small Cap Reg Gr3.31%573
Groww Large Cap Gr1.14%136

ETFs holding BLUEJET (0)

No tracked ETF holds BLUEJET ≥0.5%.

Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma